Quality Assurance Scheme Development Group
The Quality Assurance Scheme Development Group (QASDG) will develop the European Quality Assurance Scheme for Breast Cancer Services (the European QA scheme) to set common quality and safety requirements for person-centred breast cancer services in Europe. The scheme will cover all the processes of breast cancer care (screening, diagnosis, treatment, rehabilitation & supportive care, follow-up & survivorship care and palliative care) and will be underpinned by the accreditation legal framework and evidence from guidelines.
The QASDG discusses and selects the requirements within virtual working environments and in meetings organised every three months. The initial draft documents and the final versions before piloting are subject of open calls for feedback launched online. After piloting, the so validated scheme will become operative on voluntary basis throughout Europe.
The members are also invited to contribute to the other ECIBC objectives, the Digital Mammography Training Template and the European Guidelines Platform covering all processes of care (from screening to end-of-life care).
The QASDG is supported by the external contractors EA- European Co-operation for Accreditation for the accreditation legal framework and for the coordination of national accreditation bodies, by CCIb –Iberoamerican Cochrane Centre for literature review and by IQ healthcare to develop indicators.
Members and external experts
Professor Robert Mansel is Emeritus Professor of Surgery in Cardiff University School of Medicine, Cardiff. UK
His expertise in the field of breast cancer research is known worldwide and derives from many years spent studying various aspects of the subject.
His recent research interests have focused on benign breast disease, sentinel node biopsy trials in breast cancer, tamoxifen prevention therapy and innovative therapies in breast cancer. He is joint author of a textbook of benign breast disease (3rd Edn, 2009). He is a PI in the IBIS and AMAROS trials, and is chair of the LORIS trial steering committee.
He has served as President of BASO and the Association of Breast Surgeons in the past, and is the current President of the European Society of Breast Cancer Specialists. (EUSOMA).
He has had a longstanding interest in quality assurance in breast clinics and has written breast guidelines in the past and has recently served on the triage panel of NICE (UK) developing updating of the new guidelines due in 2016. He is a major contributor to EUSOMA’s Quality Indicator publications and he is an auditor in the European Breast Certification programme of Italcert with regard to Breast Centres Certification scheme.He is strongly supportive of the aims of the European Commission Initiative in Breast Cancer to improve the quality of breast care.